{"nct_id":"NCT01975389","title":"The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects","status":"TERMINATED","status_verified_date":"2019-04","start_date":"2013-10-29","start_date_type":"ACTUAL","primary_completion_date":"2017-04-03","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-03","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["PFE"]}